Ritholtz Wealth Management Edwards Lifesciences Corp Transaction History

Ritholtz Wealth Management

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	BUY	$84.3 - $94.31 $4,889 - $5,469	58 Added 2.11%	2,807 $259,000
Q1 2024 Apr 24, 2024	BUY	$72.54 - $95.56 $6,963 - $9,173	96 Added 3.62%	2,749 $262,000
Q4 2023 Jan 18, 2024	BUY	$61.71 - $77.76 $163,716 - $206,297	2,653 New	2,653 $202,000
Q2 2023 Jul 14, 2023	BUY	$81.41 - $94.33 $13,839 - $16,036	170 Added 5.94%	3,030 $285,000
Q1 2023 Apr 19, 2023	BUY	$74.26 - $84.51 $212,383 - $241,698	2,860 New	2,860 $236,000
Q3 2022 Oct 18, 2022	BUY	$82.37 - $107.29 $633,919 - $825,703	7,696 Added 228.98%	11,057 $914,000
Q2 2022 Jul 15, 2022	BUY	$86.5 - $128.27 $70,324 - $104,283	813 Added 31.91%	3,361 $320,000
Q1 2022 Apr 14, 2022	BUY	$101.96 - $128.34 $37,725 - $47,485	370 Added 16.99%	2,548 $300,000
Q4 2021 Jan 18, 2022	BUY	$106.37 - $130.68 $231,673 - $284,621	2,178 New	2,178 $282,000

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Ritholtz Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Ritholtz Wealth Management with notifications on news.